Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.11 USD | +0.34% | +0.18% | +24.97% |
Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.97% | 10.12B | |
+25.64% | 661B | |
+26.74% | 566B | |
-6.54% | 352B | |
+19.95% | 332B | |
+3.16% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-5.15% | 145B |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.
- Deutsche Bank Adjusts Catalent Price Target to $44 From $48, Maintains Hold Rating